Altria Client Services LLC
Company aimed at responsibly providing tobacco and wine to adult consumers.
Based in DC
🤖
AI Overview
With $1.4M in lobbying spend across 28 quarterly filings, Altria Client Services LLC is a significant lobbying presence. They deploy 14 individual lobbyists
$1.4M
Total Lobbying Spend
28
Quarterly Filings
1
Lobbying Firms Used
14
Individual Lobbyists
Spending by Year
| Year | Lobbying Spend |
|---|---|
| 2018 | $150K |
| 2019 | $150K |
| 2020 | $200K |
| 2021 | $200K |
| 2022 | $200K |
| 2023 | $200K |
| 2024 | $100K |
| 2025 | $200K |
Lobbying Firms
FORBES-TATE
What They Lobby For
- Issues related to the implementation of corporate tax reform; Issues related to the tobacco tax; Issues related to FY 2018 & FY 2019 AG/FDA Appropriations.
- Issues related to predicate date of electric cigarettes newly deemed tobacco products; Issues related to Medicare secondary payer.
- Issues related to the implementation of corporate tax reform; Issues related to the tobacco tax; Issues related to FY 2019 AG/FDA Appropriations.
- Issues related to predicate date of electric cigarettes newly deemed tobacco products; Issues related to Medicare secondary payer; Issues related to Tobacco to 21 Act (H.R. 4273/S.2100).
- Issues related to the implementation of corporate tax reform; Issues related to the tobacco tax; Issues related to H.R. 5961/S. 2976, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2019; Issues related to H.R. 6147, Interior, Environment, Financial Services and General Government, Agriculture, Rural Development, Food and Drug Administration, and Transportation, Housing and Urban Development Appropriations Act, 2019.
- Issues related to predicate date of electric cigarettes newly deemed tobacco products; issues related to Medicare secondary payer; issues related to raising the minimum age of purchase.
- Issues related to the implementation of corporate tax reform; issues related to the tobacco tax; issues related to the implementation of H.R. 5961/ S. 2976 FY 2019 AG/FDA Appropriations; H.R. 6147.
- Issues related to the implementation of corporate tax reform; Issues related to tobacco tax; Issues related to the implementation of H.R. 5961/S. 2976 - FY 2019 AG/FDA Appropriations & H.R. 6147 (115th Congress) - FY 2019 Appropriations; Issues regarding H.R. 3164 - Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2020.
- Issues related to predicate date of electric cigarettes newly deemed tobacco products; Issues related to Medicare secondary payer; Issues related to H.R. 2411/S. 1258 - Tobacco to 21 Act.
- Issues related to the implementation of corporate tax reform; Issues related to tobacco tax; Issues related to the implementation of H.R. 5961/S. 2976 - FY 2019 AG/FDA Appropriations & H.R. 6147 (115th Congress) - FY 2019 Appropriations; Issues regarding S. 2522 - Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2020.
Related Investigations
Big Pharma's $452M Lobbying Machine
How pharmaceutical companies spend hundreds of millions to influence health policy.
Big Tech's $150M Lobbying War
Tech giants battle over AI, antitrust, privacy, and trade.
The 2025 Tariff Panic
As tariffs return, lobbying on trade surges.
Federal Lobbying Statistics 2025
The definitive stats — $15.2B total, industry breakdowns, and trends.
What Is Lobbying? A Complete Guide
How lobbying works, who does it, and why it matters.
Explore More
Data Sources: Senate LDA Filings
Last updated: February 2026
This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.